Status:
COMPLETED
Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer in Surgical Intensive Care Unit (SICU)
Lead Sponsor:
Seoul St. Mary's Hospital
Conditions:
Fluid Overload
Fluid Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Precise assessment of postoperative volume status is important to administrate optimal fluid management. Bioelectrical impedance analysis (BIA) which measures the body composition using electric chara...
Detailed Description
Critically ill patients admitted to an intensive care unit (ICU) after surgery have commonly experienced a large amount of wide organ injury and profuse bleeding resulting in vessel damage during surg...
Eligibility Criteria
Inclusion
- Patients admitted to the surgical ICU after surgery under general anesthesia regardless of the type of surgery
- Patients who showed abnormal range of baseline ECW ratio by BIA (less than 0.390 or more than 0.405) that measured at the time of ICU admission
Exclusion
- aged under 18 years
- underwent surgery under local or regional anesthesia
- pregnant
- had bone fixation or underwent limb amputation
- had any prosthetic medical devices such as pacemaker or metallic intravascular device
- stayed in ICU for less than 48 hours
- readmitted within 48 hours after ICU discharge
- diagnosed with renal failure and receiving renal replacement therapy
- underwent extracorporeal membrane oxygenation treatment before surgery
- agreed for do-not-resuscitate
Key Trial Info
Start Date :
November 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06097923
Start Date
November 30 2021
End Date
December 31 2022
Last Update
October 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Trauma and Surgical Critical Care, Department of Surgery, Seoul St. Mary's Hospital
Seoul, Seocho-gu, Banpo-dong Banpodaero 222, South Korea, 137-701